{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:01:07Z","timestamp":1781881267928,"version":"3.54.5"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006319","name":"Centre National pour la Recherche Scientifique et Technique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119049","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:48:35Z","timestamp":1770313715000},"page":"119049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Megakaryocytes and afucosylated IgG in post-acute COVID-19: Bridging immune dysregulation and vascular pathology \u2014 A narrative review"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3831-2438","authenticated-orcid":false,"given":"Salma","family":"Labied","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Atifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Wahnou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Mabrouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othmane","family":"Jeddoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"Allaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younes","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2026.119049_bib1","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/jmv.26587","article-title":"Long COVID and chronic COVID syndromes","volume":"93","author":"Halpin","year":"2021","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119049_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/01410768211032850","article-title":"Symptoms, complications and management of long COVID: a review","volume":"114","author":"Aiyegbusi","year":"2021","journal-title":"J. R. Soc. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.119049_bib3","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.3390\/ijerph18052621","article-title":"Defining post-COVID symptoms (Post-Acute COVID, long COVID, persistent post-COVID): an integrative classification","volume":"18","author":"Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2021","journal-title":"IJERPH"},{"key":"10.1016\/j.biopha.2026.119049_bib4","first-page":"30","article-title":"Long COVID or post-acute sequelae of SARS-CoV-2 Infection (PASC) and the urgent need to identify diagnostic biomarkers and risk factors","author":"Parums","year":"2024","journal-title":"Med Sci. Monit."},{"issue":"6","key":"10.1016\/j.biopha.2026.119049_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109518","article-title":"Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms","volume":"36","author":"Peluso","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119049_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86002","article-title":"RECOVER mechanistic pathway task force. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)","volume":"12","author":"Sherif","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.biopha.2026.119049_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1157651","article-title":"Long COVID: clinical characteristics, proposed pathogenesis and potential therapeutic targets","volume":"10","author":"Kenny","year":"2023","journal-title":"Front Mol. Biosci."},{"issue":"7985","key":"10.1016\/j.biopha.2026.119049_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2026.119049_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol"},{"issue":"2","key":"10.1016\/j.biopha.2026.119049_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119049_bib11","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1172\/JCI26891","article-title":"The biogenesis of platelets from megakaryocyte proplatelets","volume":"115","author":"Patel","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2026.119049_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44031","article-title":"Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets","volume":"8","author":"Cunin","year":"2019","journal-title":"eLife"},{"issue":"6532","key":"10.1016\/j.biopha.2026.119049_bib13","doi-asserted-by":"crossref","first-page":"eabc8378","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","article-title":"Proinflammatory IgG Fc structures in patients with severe COVID-19","volume":"22","author":"Chakraborty","year":"2021","journal-title":"Nat. Immunol."},{"issue":"635","key":"10.1016\/j.biopha.2026.119049_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm7853","article-title":"Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Sci. Transl. Med"},{"issue":"596","key":"10.1016\/j.biopha.2026.119049_bib16","doi-asserted-by":"crossref","first-page":"eabf8654","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti\u2013SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"Hoepel","year":"2021","journal-title":"Sci. Transl. Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/biology11010061","article-title":"Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19","volume":"11","author":"Thye","year":"2022","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/00033197231153204","article-title":"Vascular \u201cLong COVID\u201d: a new vessel disease?","volume":"75","author":"Zanini","year":"2024","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28122","article-title":"COVID-19 immunopathology: from acute diseases to chronic sequelae","volume":"95","author":"Arish","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2026.119049_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1011936","article-title":"A review of cytokine-based pathophysiology of Long COVID symptoms","volume":"10","author":"Low","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.biopha.2026.119049_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajem.2020.09.065","article-title":"Thrombotic complications of COVID-19","volume":"39","author":"Avila","year":"2021","journal-title":"Am. J. Emerg. Med."},{"issue":"11","key":"10.1016\/j.biopha.2026.119049_bib22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/14787210.2021.1915129","article-title":"Cytokine storm associated coagulation complications in COVID-19 patients: pathogenesis and management","volume":"19","author":"Savla","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2026.119049_bib23","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1007\/s10787-025-01927-3","article-title":"Unveiling the secret of cellular metamorphosis: the crucial role of EndMT mechanisms in COVID-19-induced pulmonary fibrosis","volume":"33","author":"Zhang","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ajh.26384","article-title":"Late-onset hematological complications post COVID-19: an emerging medical problem for the hematologist","volume":"97","author":"Korompoki","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.biopha.2026.119049_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1203472","article-title":"Hematological alterations associated with long COVID-19","volume":"14","author":"Lechuga","year":"2023","journal-title":"Front Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10020-023-00610-z","article-title":"Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning","volume":"29","author":"Patel","year":"2023","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/ijms25010408","article-title":"Long COVID: molecular mechanisms and detection techniques","volume":"25","author":"Constantinescu-Bercu","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2026.119049_bib28","article-title":"Long-term immune and epigenetic dysregulation following COVID-19","volume":"283","author":"Sidiropoulou","year":"2025","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2026.119049_bib29","article-title":"Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Cell Infect. Microbiol"},{"key":"10.1016\/j.biopha.2026.119049_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103529","article-title":"COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications","volume":"168","author":"Lim","year":"2021","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119049_bib31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.202149491","article-title":"Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity","volume":"52","author":"Vicente","year":"2022","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.13393","article-title":"Fc-Fc\u03b3R interactions during infections: from neutralizing antibodies to antibody-dependent enhancement","volume":"328","author":"Edgar","year":"2024","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4049\/jimmunol.1700116","article-title":"Enhanced effector functions due to antibody defucosylation depend on the effector cell fc\u03b3 receptor profile","volume":"199","author":"Bruggeman","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib34","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1038\/s41467-022-32867-z","article-title":"Circulating multimeric immune complexes contribute to immunopathology in COVID-19","volume":"13","author":"Ankerhold","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119049_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1204661","article-title":"Fucosylated N-glycans as early biomarkers of COVID-19 severity","volume":"14","author":"Paton","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119049_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103957","article-title":"Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19","volume":"78","author":"Pongracz","year":"2022","journal-title":"EBioMedicine"},{"issue":"712","key":"10.1016\/j.biopha.2026.119049_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf6598","article-title":"Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases","volume":"15","author":"Herman","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.biopha.2026.119049_bib38","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.it.2022.08.001","article-title":"Afucosylated IgG responses in humans - structural clues to the regulation of humoral immunity","volume":"43","author":"Oosterhoff","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2026.119049_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1223936","article-title":"SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition","volume":"14","author":"Limoges","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119049_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2021.09.005","article-title":"Interaction of the inflammatory response and megakaryocytes in COVID-19 infection","volume":"104","author":"Battina","year":"2021","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-021-01082-6","article-title":"SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism","volume":"14","author":"Shen","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119049_bib42","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1182\/bloodadvances.2022009022","article-title":"Circulating SARS-CoV-2+ megakaryocytes are associated with severe viral infection in COVID-19","volume":"7","author":"Fortmann","year":"2023","journal-title":"Blood Adv."},{"issue":"16","key":"10.1016\/j.biopha.2026.119049_bib43","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1182\/blood.2021011871","article-title":"Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets","volume":"138","author":"Bye","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.biopha.2026.119049_bib44","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.immuni.2020.11.017","article-title":"Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19","volume":"53","author":"Bernardes","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12916-021-02228-6","article-title":"Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection","volume":"20","author":"Ryan","year":"2022","journal-title":"BMC Med."},{"issue":"7914","key":"10.1016\/j.biopha.2026.119049_bib46","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"issue":"7648","key":"10.1016\/j.biopha.2026.119049_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefran\u00e7ais","year":"2017","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.biopha.2026.119049_bib48","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1016\/j.cell.2023.10.008","article-title":"Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system","volume":"186","author":"Yeung","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119049_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100434","article-title":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series","volume":"24","author":"Rapkiewicz","year":"2020","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.biopha.2026.119049_bib50","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s11239-021-02593-2","article-title":"A comprehensive review of vascular complications in COVID-19","volume":"53","author":"Acharya","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"issue":"11","key":"10.1016\/j.biopha.2026.119049_bib51","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.120.317703","article-title":"Platelets can Associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19","volume":"127","author":"Zaid","year":"2020","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119049_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/1358863X231224383","article-title":"Dysregulated platelet function in patients with postacute sequelae of COVID-19","volume":"29","author":"Aggarwal","year":"2024","journal-title":"Vasc. Med"},{"issue":"3","key":"10.1016\/j.biopha.2026.119049_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00018-022-04220-6","article-title":"Hematopoietic responses to SARS-CoV-2 infection","volume":"79","author":"Elahi","year":"2022","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib54","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12959-025-00755-3","article-title":"Procoagulant effect of phosphatidylserine-exposed blood cells, endothelial cells and extracellular vesicles in patients with aortic stenosis","volume":"23","author":"Wang","year":"2025","journal-title":"Thromb. J."},{"issue":"18","key":"10.1016\/j.biopha.2026.119049_bib55","doi-asserted-by":"crossref","first-page":"14133","DOI":"10.3390\/ijms241814133","article-title":"Crosstalk between platelets and SARS-CoV-2: implications in thrombo-inflammatory complications in COVID-19","volume":"24","author":"Zhao","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2026.119049_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1254310","article-title":"Neutrophil extracellular traps and long COVID","volume":"14","author":"Shafqat","year":"2023","journal-title":"Front Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119049_bib57","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.jtha.2023.04.039","article-title":"Thromboinflammation in long COVID-the elusive key to postinfection sequelae?","volume":"21","author":"Nicolai","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.biopha.2026.119049_bib58","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.immuni.2022.10.001","article-title":"Neutrophil \u201cplucking\u201d on megakaryocytes drives platelet production and boosts cardiovascular disease","volume":"55","author":"Petzold","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH03-05-0330","article-title":"The influence of selective serotonin reuptake inhibitors on human platelet serotonin","volume":"91","author":"Maurer-Spurej","year":"2004","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu Rev. Med."},{"issue":"11","key":"10.1016\/j.biopha.2026.119049_bib61","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/stem.1777","article-title":"Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1\/2 and F-actin reorganization","volume":"32","author":"Ye","year":"2014","journal-title":"Stem Cells"},{"issue":"22","key":"10.1016\/j.biopha.2026.119049_bib62","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.cell.2023.09.013","article-title":"Serotonin reduction in post-acute sequelae of viral infection","volume":"186","author":"Wong","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119049_bib63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.csbj.2023.12.020","article-title":"SAEDC: development of a technological solution for exploratory data analysis and statistics in cytotoxicity","volume":"23","author":"Zoehler","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"3","key":"10.1016\/j.biopha.2026.119049_bib64","article-title":"Bone marrow alterations in COVID-19 infection: the root of hematological problems","volume":"71","author":"Zeylabi","year":"2023","journal-title":"Curr. Res Transl. Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119049_bib65","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/his.14969","article-title":"Bone marrow haematopoiesis in patients with COVID-19","volume":"83","author":"Marques-Maggio","year":"2023","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119049_bib66","article-title":"Megakaryocytes in the lung: history and future perspectives","volume":"7","author":"Livada","year":"2023","journal-title":"Res. Pr. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.biopha.2026.119049_bib67","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/09537104.2020.1810224","article-title":"A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients","volume":"31","author":"Roncati","year":"2020","journal-title":"Platelets"},{"issue":"7","key":"10.1016\/j.biopha.2026.119049_bib68","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00018-022-04318-x","article-title":"Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19","volume":"79","author":"Zhu","year":"2022","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119049_bib69","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00428-020-02926-1","article-title":"Increased number of pulmonary megakaryocytes in COVID-19 patients with diffuse alveolar damage: an autopsy study with clinical correlation and review of the literature","volume":"478","author":"Valdivia-Mazeyra","year":"2021","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.biopha.2026.119049_bib70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10456-022-09860-7","article-title":"Inflammation and vascular remodeling in COVID-19 hearts","volume":"26","author":"Werlein","year":"2023","journal-title":"Angiogenesis"},{"issue":"5","key":"10.1016\/j.biopha.2026.119049_bib71","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2026.119049_bib72","article-title":"Persistent immune dysregulation and metabolic alterations following SARS-CoV-2 infection","author":"Lucena Lage","year":"2025","journal-title":"Infect. Dis. (HIV\/AIDS)"},{"issue":"3","key":"10.1016\/j.biopha.2026.119049_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.120.315867","article-title":"Letter by Brambilla et al regarding Article, \u201cPlatelets promote thromboinflammation in SARS-CoV-2 Pneumonia.\u201d","volume":"41","author":"Brambilla","year":"2021","journal-title":"ATVB"},{"issue":"1","key":"10.1016\/j.biopha.2026.119049_bib74","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2024.2313362","article-title":"Increased circulating platelet-derived extracellular vesicles in severe COVID-19 disease","volume":"35","author":"Helin","year":"2024","journal-title":"Platelets"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:44:39Z","timestamp":1781880279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":74,"alternative-id":["S0753332226000818"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119049","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Megakaryocytes and afucosylated IgG in post-acute COVID-19: Bridging immune dysregulation and vascular pathology \u2014 A narrative review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119049"}}